Table 2.

Drugs classified as fall-risk increasing drugs in the IMPROveFALL study

Category	Drug type
Central nervous system	anxiolytics/hypnotics (benzodiazepines and others); antidepressants (tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and monoamine oxidase inhibitors), neuroleptics (dopamine D2-receptor agonists and serotonin dopamine receptor antagonists)
Cardiovascular	Antihypertensives (diuretics, beta-adrenoceptor blockers, alpha-adrenoceptor blockers, centrally acting antihypertensives, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers); Anti-arrhythmic drugs (Antiarrhythmics, nitrates, digoxin, vasodilators)
Anti-inflammation	NSAIDs
Gastro-Intestinal	Antacids (H-2 receptor antagonists)
Analgesics	Opioids
Pulmonary	Sympathomimetics, anti-histaminics
Diuretics	Thiazide diuretics, loop diuretics